{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:58:57Z","timestamp":1793825937962,"version":"4.6.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Numerous genetic discoveries and the advent of clinical telomere length testing have led to the recognition of a spectrum of telomere biology disorders (TBDs) beyond the classic dyskeratosis congenita (DC) triad of nail dysplasia, abnormal skin pigmentation, and oral leukoplakia occurring with pediatric bone marrow failure. Patients with DC\/TBDs have very short telomeres for their age and are at high risk of bone marrow failure, cancer, pulmonary fibrosis (PF), pulmonary arteriovenous malformations, liver disease, stenosis of the urethra, esophagus, and\/or lacrimal ducts, avascular necrosis of the hips and\/or shoulders, and other medical problems. However, many patients with TBDs do not develop classic DC features; they may present in middle age and\/or with just 1 feature, such as PF or aplastic anemia. TBD-associated clinical manifestations are progressive and attributed to aberrant telomere biology caused by the X-linked recessive, autosomal dominant, autosomal recessive, or de novo occurrence of pathogenic germline variants in at least 18 different genes. This review describes the genetics and clinical manifestations of TBDs and highlights areas in need of additional clinical and basic science research.<\/jats:p>","DOI":"10.1182\/hematology.2022000394","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:14:32Z","timestamp":1670602472000},"page":"637-648","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":104,"title":["Dyskeratosis congenita and telomere biology disorders"],"prefix":"10.1182","volume":"2022","author":[{"given":"Sharon A.","family":"Savage","sequence":"first","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"12","key":"2022120916104450300_hem2022000394C1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"2022120916104450300_hem2022000394C2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol"},{"issue":"4","key":"2022120916104450300_hem2022000394C3","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.170","article-title":"Clinical utility gene card for: dyskeratosis congenita\u2014update 2015","volume":"23","author":"Dokal","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"2022120916104450300_hem2022000394C4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2022120916104450300_hem2022000394C5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","article-title":"The genetics and clinical manifestations of telomere biology disorders","volume":"12","author":"Savage","year":"2010","journal-title":"Genet Med"},{"issue":"6761","key":"2022120916104450300_hem2022000394C6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"issue":"1","key":"2022120916104450300_hem2022000394C7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"issue":"4","key":"2022120916104450300_hem2022000394C8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaad.2017.10.017","article-title":"Beyond the triad: inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita","volume":"78","author":"Ward","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2022120916104450300_hem2022000394C9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/hematology.2020000170","article-title":"Extrahematopoietic manifestations of the short telomere syndromes","volume":"2020","author":"Schratz","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2022120916104450300_hem2022000394C10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MCP.0000000000000475","article-title":"Pulmonary phenotypes associated with genetic variation in telomere-related genes","volume":"24","author":"Hoffman","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"2022120916104450300_hem2022000394C11","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14068.1","article-title":"Beginning at the ends: telomeres and human disease","volume":"7","author":"Savage","year":"2018","journal-title":"F1000Res"},{"issue":"1","key":"2022120916104450300_hem2022000394C12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"November","key":"2022120916104450300_hem2022000394C13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-032918-021921","article-title":"Shelterin-mediated telomere protection","volume":"52","author":"de Lange","year":"2018","journal-title":"Annu Rev Genet"},{"issue":"5","key":"2022120916104450300_hem2022000394C14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"1741","key":"2022120916104450300_hem2022000394C15","doi-asserted-by":"crossref","first-page":"20160436","DOI":"10.1098\/rstb.2016.0436","article-title":"Reflections on telomere dynamics and ageing-related diseases in humans","volume":"373","author":"Aviv","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2022120916104450300_hem2022000394C16","first-page":"31","article-title":"Diagnosing telomere biology disorders","author":"Bertuch","year":"2022"},{"issue":"3","key":"2022120916104450300_hem2022000394C17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.1084","article-title":"Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus","volume":"44","author":"Anderson","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"2022120916104450300_hem2022000394C18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/hematology.2021000246","article-title":"When to worry about inherited bone marrow failure and myeloid malignancy predisposition syndromes in the setting of a hypocellular marrow","volume":"2021","author":"Narla","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1-2","key":"2022120916104450300_hem2022000394C19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrfmmm.2011.04.003","article-title":"Telomere length measurement\u2014caveats and a critical assessment of the available technologies and tools","volume":"730","author":"Aubert","year":"2012","journal-title":"Mutat Res"},{"issue":"6","key":"2022120916104450300_hem2022000394C20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00439-021-02257-4","article-title":"High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders","volume":"140","author":"Norris","year":"2021","journal-title":"Hum Genet"},{"issue":"3","key":"2022120916104450300_hem2022000394C21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"issue":"10","key":"2022120916104450300_hem2022000394C22","doi-asserted-by":"crossref","first-page":"E2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2022120916104450300_hem2022000394C23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2022120916104450300_hem2022000394C24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2014.114389","article-title":"Telomere length in inherited bone marrow failure syndromes","volume":"100","author":"Alter","year":"2015","journal-title":"Haematologica"},{"issue":"13","key":"2022120916104450300_hem2022000394C25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N Engl J Med"},{"issue":"22","key":"2022120916104450300_hem2022000394C26","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"March","key":"2022120916104450300_hem2022000394C27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpeds.2020.09.038","article-title":"Gastrointestinal hemorrhage: a manifestation of the telomere biology disorders","volume":"230","author":"Himes","year":"2021","journal-title":"J Pediatr"},{"issue":"10","key":"2022120916104450300_hem2022000394C28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2016.147769","article-title":"Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis","volume":"101","author":"Walne","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"2022120916104450300_hem2022000394C29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/ijms18081765","article-title":"Correlation of leukocyte telomere length measurement methods in patients with dyskeratosis congenita and in their unaffected relatives","volume":"18","author":"Khincha","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2022120916104450300_hem2022000394C30","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"key":"2022120916104450300_hem2022000394C31","first-page":"83","article-title":"Genetic counseling for families","author":"Tryon","year":"2022"},{"key":"2022120916104450300_hem2022000394C32","first-page":"69","article-title":"The genetics of dyskeratosis congenita and telomere biology disorders","author":"Savage","year":"2022"},{"issue":"7","key":"2022120916104450300_hem2022000394C33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.2021011980","article-title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue","volume":"139","author":"Sharma","year":"2022","journal-title":"Blood"},{"issue":"16","key":"2022120916104450300_hem2022000394C34","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood.2021010791","article-title":"Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects","volume":"139","author":"Kermasson","year":"2022","journal-title":"Blood"},{"issue":"15","key":"2022120916104450300_hem2022000394C35","doi-asserted-by":"crossref","first-page":"eaay3511","DOI":"10.1126\/sciadv.aay3511","article-title":"Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance","volume":"6","author":"Toufektchan","year":"2020","journal-title":"Sci Adv"},{"issue":"4","key":"2022120916104450300_hem2022000394C36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"issue":"2","key":"2022120916104450300_hem2022000394C37","first-page":"501","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2022120916104450300_hem2022000394C38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ajh.24545","article-title":"Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations","volume":"91","author":"Xu","year":"2016","journal-title":"Am J Hematol"},{"issue":"11","key":"2022120916104450300_hem2022000394C39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/humu.22397","article-title":"Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene","volume":"34","author":"Alder","year":"2013","journal-title":"Hum Mutat"},{"key":"2022120916104450300_hem2022000394C40","author":"Agarwal","year":"2022"},{"issue":"10","key":"2022120916104450300_hem2022000394C41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41576-019-0139-x","article-title":"Somatic genetic rescue in Mendelian haematopoietic diseases","volume":"20","author":"Revy","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"18","key":"2022120916104450300_hem2022000394C42","doi-asserted-by":"crossref","first-page":"e147598","DOI":"10.1172\/JCI147598","article-title":"Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders","volume":"131","author":"Schratz","year":"2021","journal-title":"J Clin Invest"},{"issue":"8","key":"2022120916104450300_hem2022000394C43","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.gim.2022.04.017","article-title":"The gene curation coalition: a global effort to harmonize gene-disease evidence resources","volume":"24","author":"DiStefano","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"2022120916104450300_hem2022000394C44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10456-018-9640-7","article-title":"Understanding the evolving phenotype of vascular complications in telomere biology disorders","volume":"22","author":"Higgs","year":"2019","journal-title":"Angiogenesis"},{"issue":"11","key":"2022120916104450300_hem2022000394C45","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1158\/1078-0432.CCR-17-0465","article-title":"Recommendations for childhood cancer screening and surveillance in DNA repair disorders","volume":"23","author":"Walsh","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2022120916104450300_hem2022000394C46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1601-0825.2007.01394.x","article-title":"Oral and dental phenotype of dyskeratosis congenita","volume":"14","author":"Atkinson","year":"2008","journal-title":"Oral Dis"},{"issue":"4","key":"2022120916104450300_hem2022000394C47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"issue":"2","key":"2022120916104450300_hem2022000394C48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/acel.12041","article-title":"The gastrointestinal manifestations of telomere-mediated disease","volume":"12","author":"Jonassaint","year":"2013","journal-title":"Aging Cell"},{"key":"2022120916104450300_hem2022000394C49","first-page":"41","article-title":"Chapter two\u2014human telomeres and telomere biology disorders","author":"Savage","year":"2014"},{"issue":"9","key":"2022120916104450300_hem2022000394C50","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2008-05-153445","article-title":"TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes","volume":"112","author":"Walne","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2022120916104450300_hem2022000394C51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2022120916104450300_hem2022000394C52","doi-asserted-by":"crossref","first-page":"103760","DOI":"10.1016\/j.ebiom.2021.103760","article-title":"Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita","volume":"75","author":"Thompson","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"2022120916104450300_hem2022000394C53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2013","journal-title":"Brit J Haematol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/637\/2021871\/637savage.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/637\/2021871\/637savage.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:15:30Z","timestamp":1670602530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/637\/493529\/Dyskeratosis-congenita-and-telomere-biology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000394","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}